Expression of BCL-2 was detected in 12% of pancreatic cancers and the sensitivity and specificity of immunostaining were confirmed by the prominent expression of BCL-2 in infiltrating lymphocytes in all cases examined. The gene discussed is BCL2; the disease is pancreatic neoplasm.